Digital Content 
NEWS #PharmaBuzz
28 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/28/3122491/33240/en/New-Publication-in-Expert-Review-of-Anti-infective-Therapy-Evaluates-Brincidofovir-as-Potential-Antiviral-Treatment-for-Mpox.html
16 Jul 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/who-extended-global-emergency-status-of-mpox-epidemic-development-of-1049241
14 Jul 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/adaptive-clinical-protocol-design-for-phase-ii-mpox-clade-i-treatment-1048280
26 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/26/2953776/33240/en/Emergent-BioSolutions-Announces-the-Execution-of-Contract-Options-Valued-at-67-4-Million-to-Procure-Additional-TEMBEXA-brincidofovir-to-Support-National-Preparedness-Efforts.html
28 Sep 2022
// Tyler Patchen ENDPTS
https://endpts.com/emergent-closes-on-buying-smallpox-drug-tembexa-from-chimerix-with-a-238m-payment/
27 Sep 2022
// PHARMACEUTICAL-TECHNOLOGY
https://www.pharmaceutical-technology.com/news/emergent-smallpox-antiviral/
Share 